ISRCTN36964733已完成不适用
Effectiveness of bracing patients with adolescent idiopathic scoliosis
Erasmus Medical Centre (Netherlands)0 个研究点目标入组 100 人开始时间: 2006年2月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Firls and boys in the age group 8-15 years
- •2. Diagnosis of AIS has been established by an orthopaedic surgeon
- •3. not yet been treated by bracing or surgery
- •4. Further growth of physical height is still expected based on medical examination and maturation characteristics (Risser sign) established by X-ray. To expect further growth of physical height, patients only with Risser sign <3 will be included.
- •5. As agreed in the consensus by the different health professionals in the orthopaedic field, the Cobb angle should either be minimally 22 and maximally 29 degrees with established progression of more than 5 degrees or should be minimally 30 and maximally 35 degrees; progression for the latter is not necessarily established.
排除标准
- •Patients with other forms of scoliosis (e.g. as a result of neuromuscular diseases)
研究者
相似试验
招募中
不适用
Effectiveness of bracing patients with adolescent idiopathic scoliosis.Adolescent Idiopathic Scoliosis (AIS)NL-OMON23157Erasmus MC, dept. of Public HealthP.O. Box 17383000 DR Rotterdamthe Netherlandstel.: + 31 10 4087714fax: + 31 10 4089449100
进行中（未招募）
Unknown
Strengthening programme for ambulant adolescents with cerebral palsyNervous System DiseasesCerebral palsyISRCTN68282588niversity of Oxford334
进行中（未招募）
1 期
Treatment study for children and adolescents with Acute Promyelocytic LeukemiaEUCTR2017-002383-40-ITAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
进行中（未招募）
1 期
Treatment study for children and adolescents with Acute Promyelocytic LeukemiaEUCTR2017-002383-40-CZAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90
进行中（未招募）
1 期
Treatment study for children and adolescents with Acute Promyelocytic Leukemiaacute promyelocytic leukemia (APL) in children and adolescentsEUCTR2017-002383-40-SEAIEOP- Associazione Italiana Ematologia Oncologia Pediatrica90